Full Breakdown
Bollywood Actor Ajay Devgn Challenges Maharashtra FDA Notice Over Vimal Elaichi Ads
By Drooid · · How we work
In this breakdown
01
Core Event: High Court Petition Against Surrogate Advertising Allegations
- On October 30, 2026, FDA Commissioner Tukaram Mundhe said the department had completed investigations and found violations by actors Ajay Devgn, Shah Rukh Khan and Tiger Shroff in connection with advertisements for “Vimal Elaichi.” The agency plans to refer the matter for adjudication before the joint commissioner next week.
- Ajay Devgn has filed a petition in the Bombay High Court contesting the show-cause notice, arguing that the notice was arbitrarily addressed to him rather than to the manufacturing company.
- A division bench comprising Chief Justice Mahesh Chandra Tripathi and Justice Advait Sethna is scheduled to hear the petition on November 4.
02
Background & Context: Surrogate Advertising and Maharashtra Ban
- “Vimal Elaichi” is promoted as a flavored product, but the Maharashtra Food and Drug Administration (FDA) alleges the campaign functions as surrogate promotion for “Vimal Pan Masala,” a chewable tobacco product prohibited under state law.
- Maharashtra bans the manufacture, storage, transport, distribution and sale of pan masala and gutkha, citing public-health concerns.
Visual evidence
Images from the story
03
Data & Statistics: Health Impact of Smokeless Tobacco
- National data registries report over 1,43,000 new oral-cancer cases and nearly 80,000 deaths annually in India, with smokeless tobacco identified as a major contributor.
04
Official Statements & Responses
- Tukaram Mundhe (FDA commissioner) stated that the assistant commissioner had completed the investigation, found rule violations, and that the case would be proposed for adjudication before the joint commissioner within the next week.
- In his petition, Ajay Devgn contended that regulatory action should target the product manufacturer, not individual brand ambassadors, and described the notice as “arbitrary.”
- The Bombay High Court has not yet ruled; proceedings will continue pending any court direction.
05
Verbatim Quotes
- “Three actors sought time to respond. The assistant commissioner has completed the investigation and found that they violated the state's rules in the Vimal Pan Masala advertising case. The proceedings have now concluded, and the case will be proposed for adjudication before the joint commissioner, who is the competent authority, by next week,” — Tukaram Mundhe, FDA commissioner
06
Legal Proceedings Timeline
- October 30, 2026 – FDA commissioner announces completion of investigations and upcoming adjudication.
- November 4 – Scheduled hearing of Devgn’s petition before a division bench of the Bombay High Court.
07
What’s Next
- The adjudication process before the joint commissioner is expected to begin next week, after which any penalties or further orders will be determined. The High Court’s decision on Devgn’s challenge will be delivered after the November 4 hearing.